Compare VERA & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VERA | FBNC |
|---|---|---|
| Founded | 2016 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2021 | 1995 |
| Metric | VERA | FBNC |
|---|---|---|
| Price | $38.26 | $52.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $81.30 | $61.25 |
| AVG Volume (30 Days) | ★ 940.2K | 167.9K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | N/A | ★ 45.65 |
| EPS | N/A | ★ 2.68 |
| Revenue | N/A | ★ $67,623,000.00 |
| Revenue This Year | N/A | $37.82 |
| Revenue Next Year | $445.28 | $2.30 |
| P/E Ratio | ★ N/A | $19.68 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $18.53 | $34.50 |
| 52 Week High | $56.05 | $62.64 |
| Indicator | VERA | FBNC |
|---|---|---|
| Relative Strength Index (RSI) | 36.82 | 30.51 |
| Support Level | $37.20 | $45.57 |
| Resistance Level | $43.21 | $54.37 |
| Average True Range (ATR) | 2.18 | 1.58 |
| MACD | -0.00 | -0.58 |
| Stochastic Oscillator | 17.47 | 2.04 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing and investment advisory services.